Cytokinetics Announces Publication Relating to Novel Smooth Muscle Myosin Inhibitor
SOUTH SAN FRANCISCO, Calif., Nov. 07, 2016 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (Nasdaq:CYTK) a leader in muscle biology and the mechanics of muscle performance, today announced the publication of preclinical data characterizing a smooth muscle myosin ( …